We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to avoid the top 10 reasons heavy trailers don't pass the Individual Vehicle Approval (IVA) inspection.
How lorries are inspected when they're being approved under the Individual Vehicle Approval (IVA) scheme to make sure they're safe to be used.
Patients with severe alopecia areata (patchy hair loss) could access a new medicine to help treat their condition.
Data on prevalence, risk and related factors, service contacts, and quality and outcomes.
HGV driver vacancies statistics on the number of businesses reporting vacancies, the impact on deliveries and financial incentives up to December 2023.
Study researching the feasibility of a national trial of longer heavier vehicles (LHVs) within Great Britain.
This project look at sources of heavy metal contamination in road dust and to apportion the relative contribution, where possible, of different sources.
Project designing and piloting a way to measure greenhouse gas and air quality pollutant emissions from heavy goods vehicles.
Ways to load items on a goods vehicle safely.
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
A report identifying groups in the population at equivalent risk from severe COVID-19 outcomes to any condition in the highest-risk cohort.
OPSS would like to invite any interested parties, to submit any scientific information relevant to the safety assessment of nanomaterials used in cosmetics.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).